A significant capacity of SGLT-1 to reabsorb glucose is unmasked by SGLT-2 inhibition (~40–50% reabsorption in normoglycemia) and during hyperglycemia, which both enhance glucose delivery to the late proximal tubule. This evidence concerns the gene SLC5A2 and Hyperglycemia.